CCNB1 has been shown to be upregulated in HCV-induced HCC [44], while AEBP1 has been demonstrated to manifest a proinflammatory function by up-regulating NF-kappaB and suggested as a potential therapeutic target for the treatment of various chronic inflammatory diseases and cancer [23]. The gene discussed is AEBP1; the disease is cancer.